8.Progress in management of patent ductus arterious in preterm infants with gestational age of <28 weeks.
Chinese Journal of Contemporary Pediatrics 2015;17(10):1142-1147
Patent ductus arteriosus (PDA) is a common problem encountered in the early neonatal period, particularly in preterm infants. Optimal management of PDA in preterm infants remains controversial. Despite considerable historical and physiological data indicating a persistent PDA may be harmful, robust evidence of long-term benefits or harms from treatment is lacking. This has been equated to a lack of benefit but is also a reflection of the fact that many clinical trials were designed to assess the effects of short-term (2-8 days) rather than prolonged exposure to a PDA. No clinical trials have been designed to assess the effects of prolonged exposure of persistent PDA on morbidity and mortality of very premature infants. Significant changes in management of PDA, i.e., less treatment for PDA, have evolved in recent years. This paper reviews the current literature and evidence for treatment options and research progress of PDA in infants with gestational age of <28 weeks.
Ductus Arteriosus, Patent
;
therapy
;
Gestational Age
;
Humans
;
Infant, Newborn
;
Infant, Premature
9.A case of transcatheter closure of inferior vena cava type atrial septal defect with patent ductus arteriosus occlusion device guided by 3D printing technology.
Fan YANG ; Hong ZHENG ; Jianhua LYU ; Xinling YANG ; Yankun YANG ; Ying PANG ; Fang LIANG ; Gejun ZHANG ; Zhongying XU ; Shiliang JIANG ; Bin LYU ; Fengyun MENG ; Baojian HAO
Chinese Journal of Cardiology 2015;43(7):631-633
Result Analysis
Print
Save
E-mail